{
    "msg": "获取章节试题成功",
    "data": {
        "test": {
            "ReturnMessage": "取数据成功",
            "APPEName": "ZY_LCZY_YTMJ",
            "GenDate": "Tue May 14 2019 23:15:59 GMT+0800 (CST)",
            "StyleItems": [
                {
                    "StyleID": 1,
                    "Style": "A1型题",
                    "Explain": "A1型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 13,
                    "TestItems": [
                        {
                            "Title": "888a24160bebadcd936d5b8bc154cb261d09d1d5790ef46d441f0dd6aa94f36f",
                            "Explain": "硝苯地平是治疗变异型心绞痛的首选药。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "尼莫地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "氨氯地平"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "地尔硫[caozhuo.gif]"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "尼群地平"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43000517,
                            "ATestID": 43000517,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "0a146e8ffd1098b809d96903d700fe10f7a5510ec1a8c3a355578fe98b2a8927f27b62e35c3a3ff2405cfae92fabe0730f81974873abd6bed31ffda5caf9fafca8cfc3369d0f2394",
                            "Explain": "洋地黄中毒所致的室性早搏除停用洋地黄外，首选钾盐和苯妥英钠。急性心肌梗塞所致室性早搏，首选利多卡因50一100mg，静脉注射，如果无效可间隔5—10分钟后重复静脉注射，1小时内用药总量不超过0．3g。有效后以每分钟1—4mg的速率静脉滴注维持。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "B",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "苯妥英钠"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "利多卡因"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "普鲁卡因胺"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002689,
                            "ATestID": 43002689,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "dabc2f69442e48cad4b778a3e3a7a981ca857d968a36773d886589a1b91777183990739cccc44ff116481b4932c67caac51c36197077f0cc070625f7b35bd649fbf31c411ac12d0c7506b45647c86acc",
                            "Explain": "地高辛可以抑制窦性激动发放和房室传导从而减慢心率，减少心肌耗氧量，达到缓解心衰的目的。但地高辛一旦过量和中毒，就会引起严重窦性心动过缓，还有房室传导阻滞，此时必须停药并可以使用苯妥英钠，但轻度心动过缓和一度房室传导阻滞并不一定就提示过量和中毒，这时候最好加强观察，用阿托品虽然暂时提高了心率，但会掩盖中毒，所以并不合适选用。所以答案选择C。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "C",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "Content": "阿托品",
                                    "ItemName": "A"
                                },
                                {
                                    "Content": "异丙肾上腺素",
                                    "ItemName": "B"
                                },
                                {
                                    "Content": "苯妥英钠",
                                    "ItemName": "C"
                                },
                                {
                                    "Content": "肾上腺素",
                                    "ItemName": "D"
                                },
                                {
                                    "Content": "氯化钾",
                                    "ItemName": "E"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002691,
                            "ATestID": 43002691,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "1afcbccd1c60d0f364aa0de7d12c78c262f5046f091420e1872719b50ff75929ec9d3a94b1a189af",
                            "Explain": "有促心律失常作用，产生心脏停搏及传导阻滞，较多见于原有心脏病患者，也可发生室性早搏、室性心动过速及室颤。诱发室性心动过速（扭转性室性心动过速）或室颤，可反复自发自停，发作时伴晕厥现象，此作用与剂量无关，可发生于血药浓度尚在治疗范围内或以下时。本品可使血管扩张产生低血压，个别可发生脉管炎。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "金鸡纳反应"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "药热，血小板减少"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "奎尼丁晕厥"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "胃肠道反应"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "心室率加快"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002692,
                            "ATestID": 43002692,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3bb598f82ab5f796e3462f92e3a846ec98ef7fae423893c7bf9b24dc4dbafefacb96f1321df4022d",
                            "Explain": "适用于因急性心肌梗塞、外科手术、洋地黄中毒及心脏导管等所致急性室性心律失常，包括室性早搏、室性心动过速及室颤。对室上性心动过速没有效果。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "C",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "心室颤动"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "室性期前收缩"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "室上性心动过速"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "强心苷引起的室性心律失常"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "心肌梗死所致的室性早搏"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002693,
                            "ATestID": 43002693,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "823f9d978acaa82637f0edb4f55e0c2be57f90832ee7d49e5a60953426f91ee904feb267439a08110f14966c6aef9261bdd2a926ea9ad27002fa09ed8f57b61f",
                            "Explain": "普萘洛尔为非选择性β1与β2肾上腺素受体阻滞剂，使心率减慢，心肌收缩力减弱，心排血量减少，初期因外周阻力反射性增加（使α受体作用相对增强），故降压作用不明显，肾血流量与肾小球滤过率、冠状动脉及其他内脏器官血流量均减少。普萘洛尔能影响肾上腺素能神经元功能、中枢神经系统的血压调节压力感受器的敏感性，可竞争性对抗异丙肾上腺上腺上腺素和去甲肾上腺上腺上腺素的作用。血浆肾素活肾素活性因β2受体被阻断而降低，还可致血管收缩，支气管痉挛。有增强胰岛素降低血糖的作用，对前列腺素E2的合用亦有影响。概括其作用特点为温和、缓慢、持久，能抑制肾素分泌，无直立性低血压症。治疗震颤的机制可能与β2受体有关，也有可能是中枢作用。治疗量不延长浦氏纤维的有效不应期。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "D",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "阻断心肌β受体"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "降低窦房结的自律性"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "降低普肯耶纤维的自律性"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "治疗量就延长浦氏纤维的有效不应期"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "延长房室结的有效不应期"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002694,
                            "ATestID": 43002694,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "da1019340a6ad64afbbeccf886d19b28681e34cdcbf262171b834ee1bade3c93824ab462dc650f3dbff7dbc908035a957c35f151e08b94746cdd7205b4e4ffdf",
                            "Explain": "是窄谱抗心律失常药、低剂量时，可促进心肌细胞内K[~+.gif]外流，降低心肌的自律性，而具有抗室性心率失常作用；在治疗剂量时，对心肌细胞的电活动、房室传导和心肌的收缩无明显影响；血药浓度进一步升高，可引起心脏传导速度减慢，房室传导阻滞，抑制心肌收缩力和使心排血量下降。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "是窄谱抗心律失常药"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "能缩短普肯耶纤维的动作电位时程和有效不应期"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "C",
                                    "Content": "对传导速度的作用，受细胞外液K[~+.gif]浓度的影响"
                                },
                                {
                                    "HasImg": 1,
                                    "ItemName": "D",
                                    "Content": "对心肌的直接作用是抑Na[~+.gif]内流，促K[~+.gif]外流"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "治疗剂量就能降低窦房结的自律性"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002695,
                            "ATestID": 43002695,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "dfc8a755e077125de2b176d27cfda7d30d93763c63a742363dd2fe3efaece6e7439a2a42ee1301e999e9c024279eb0646c1e8b499246f81e0e48345393fed2130f1cf4d9faf137b7dcb909a3a59affc2",
                            "Explain": "胺碘酮属Ⅲ类抗心律失常药。具有轻度非竞争性的α及β肾上腺素受体阻滞剂。且具轻度Ⅰ及Ⅳ类抗心律失常药性质。主要电生理效应是延长各部心肌组织的动作电位及有效不应期，有利于消除折返激动。抑制心房及心肌传导纤维的快钠离子内流，减慢传导速度。减低窦房结自律性。对静息膜电位及动作电位高度无影响。对房室旁路前向传导的抑制大于逆向。由于复极过度延长，心电图有Q-T间期延长及T波改变。静注有轻度负性肌力作用，但通常不抑制左室功能。对冠状动脉及周围血管有直接扩张作用。可影响甲状腺素代谢。胺碘酮延长心室肌APD作用机制有关的主要离子通道钾通道。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "E",
                            "Difficulty": "中",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "钠通道"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "钙通道"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "镁通道"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "氯通道"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "钾通道"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002696,
                            "ATestID": 43002696,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "c21dcaaf28a474b66998272cd7ed2a8472fd33b1354293a731433251d86a83a96b5c4b8fc48e1661",
                            "Explain": "抗心律失常药物：①Ⅰ类：钠通道阻滞剂，ⅠA类适度阻滞钠通道，如奎尼丁等药；ⅠB类轻度阻滞钠通道，如利多卡因等药；ⅠC类明显阻滞钠通道，如普罗帕酮等药。②Ⅱ类：肾上腺素受体阻断剂，代表性药物为普萘洛尔。③Ⅲ类：选择性延长复极过程，如胺碘酮。④Ⅳ类：钙拮抗药，阻滞钙通道而抑制Ca[SB2jia.gif]内流，代表性药物有维拉帕米。故选C。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "普罗帕酮"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "硝苯地平"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015439,
                            "ATestID": 43015439,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "70927ee1833ab4a20d652e5e38cb6ca7487f0a82e7b524ea529f59fe24e86806a7ef277eb9944f140511690011b5ccaa",
                            "Explain": "利多卡因的心脏毒性低，主要用于室性心律失常。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "强心苷（甙）"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "普萘洛尔"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015441,
                            "ATestID": 43015441,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "fee54a486fa44768e3b7a190f36a5268bf81fc6f1db2456d",
                            "Explain": "胺碘酮延长APD的作用不依赖于心率的快慢，无翻转使用依赖性，胺碘酮对心脏钾、钠、钙等多种离子通道均有抑制作用。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "延长APD，阻滞Na[SBjia.gif]内流"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "缩短APD，阻滞Na[SBjia.gif]内流"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "延长ERP，促进K[SBjia.gif]外流"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "缩短APD，阻断β受体"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "缩短ERP，阻断α受体"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015442,
                            "ATestID": 43015442,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "820758cb6628658555e33d77d24310b177eb7b1b988fb820683dcd3c4c25eedf59665f5c50989b49e3f5f924953ed36d36199dc40f776284cf5e3dd8b1581dd946b3f6737db935e9a1bdbcbcb839c2e0",
                            "Explain": "胺碘酮适用于下列心律失常，尤其合并器质性心脏病如冠状动脉供血不足及心力衰竭：①房性心律失常（心房扑动、心房颤动转律和转律后窦性心律的维持）；②结性心律失常；③室性心律失常（治疗危及生命的室性期前收缩和室性心动过速以及室性心动过速或心室颤动的预防）；④伴W-P-W综合征的心律失常。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "索他洛尔"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "多巴酚丁胺"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "氟卡尼"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "普罗帕酮"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015443,
                            "ATestID": 43015443,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "fee54a486fa44768940c057ac28a7c87392cc089b1f9822a8629ca9ae216f189",
                            "Explain": "胺碘酮对心脏多种离子通道均有抑制作用，降低窦房结、浦肯野纤维的自律性和传导性，明显延长APD和ERP，延长Q-T间期和QRS波。此外，胺碘酮尚有非竞争性拮抗α、β肾上腺素能受体作用和扩张血管平滑肌作用，能扩张冠状动脉，增加冠脉流量，减少心肌耗氧量。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "增加心肌耗氧量"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "明显延长心肌不应期"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "增加心肌自律性"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "加快心肌传导"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "收缩冠状动脉"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015444,
                            "ATestID": 43015444,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 5,
                    "Style": "A1/A2型题",
                    "Explain": "A1/A2型题：每一道考试题下面有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 2,
                    "TestItems": [
                        {
                            "Title": "8419e849a5e7c8fe8a7892b3dc7ae35f2a5424251b1b5e549f007d2c2ae88f3a7ce7bab22cd6c53241497a757b2ade382180a268f7f8624f45256ec3ee0cdef0c502ce4ccc8500a3",
                            "Explain": "普萘洛尔为β受体阻断剂，用于房性及室性期前收缩、窦性及室上性心动过速、心绞痛、急性心肌梗死、高血压等；可乐定适用于治疗高血压；利多卡因主要用于麻醉和抢救心律失常；硝酸甘油用于心绞痛急性发作，也用于急性左心衰竭；氢氯噻嗪是一种中效利尿药，有降压作用。故选B。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "可乐定"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "普萘洛尔"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "氢氯噻嗪"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "硝酸甘油"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "利多卡因"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 41000530,
                            "ATestID": 41000530,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3428e7a252e42e3a15b21f1b141f5ac1829048dd70ec10042ccdf34cd13d3c5a44d35f228ef13710102259ca720e224af5043dd9e1d3b4b1",
                            "Explain": "用于心房颤动的抗心律失常药物有两类：①转复心房颤动、恢复窦性心律和预防复发的药物，包括ⅠA类（如奎尼丁）、ⅠC类（如普罗帕酮，莫雷西嗪）和Ⅲ类（胺碘酮、索他洛尔）抗心律失常药物；②减慢心室率的药物，包括β受体阻断剂、非二氢吡啶类钙拮抗剂（维拉帕米和地尔硫[zhuo.gif]）以及洋地黄类药物。利多卡因主要作用于各种室性心律失常，如期前收缩、心动过速、心室颤动等，而不用于心房颤动，故选C。",
                            "TestPoint": "",
                            "Answer": "C",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "强心苷"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "利多卡因"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "维拉帕米"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "普萘洛尔"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 41000531,
                            "ATestID": 41000531,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 2,
                    "Style": "A2型题",
                    "Explain": "A2型题：每一道考题是以一个小案例出现的，其下面都有A、B、C、D、E五个备选答案。请从中选择一个最佳答案。",
                    "Score": 1,
                    "Type": "ATEST",
                    "SubType": "",
                    "TestCount": 2,
                    "TestItems": [
                        {
                            "Title": "02b50e5b583d09035010e035562938275b1cedf648f62942e0616c9315b64224a3dc4178cc3a8bbc29672e8a8d57d0fc6a99822d2c2a31b4eb3875991927f71b92ad0900700aa5e540636a291e2f1c5f03d55c2c3d37ec7b6665a8bc7c05f1381a605cb1df0708d9ba70b181281f0f91042be38aa7095dcc3ea5ee270994acd78fc85b57bf62a0e7",
                            "Explain": "选用作用于心室的Ⅰ类和Ⅲ类药。对于期前收缩患者，应综合考虑患者长期应用抗心律失常药物治疗的风险和收益，伴有心衰和心肌梗死的患者禁用Ⅰ类抗心律失常药物。有潜在致命危险的室性期前收缩常需紧急静脉给药。急性心肌梗死初期可选静脉内使用胺碘酮或利多卡因。心肌梗死后若无禁忌，则常有β受体阻滞剂或胺碘酮治疗。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "A",
                            "Difficulty": "难",
                            "SelectedItems": [
                                {
                                    "HasImg": 1,
                                    "ItemName": "A",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "B",
                                    "Content": "索他洛尔"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "C",
                                    "Content": "美西律"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "D",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "HasImg": 0,
                                    "ItemName": "E",
                                    "Content": "普罗帕酮"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43002697,
                            "ATestID": 43002697,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        },
                        {
                            "Title": "3386b1c8381c86b0fb6cb7927ed2c56a6ff368ae871149c16320ed3228c4aa600d846c0da856ad23de502861a3f0908bc769d6bc9a24f444bc30cbbedeade5d238efc1fbb1ba9a7b699cefc49bcba4923bcc20958980dc982638fc202b6a757517a8cfd13a996573826b6bf43ba16b6f6173d4a573b856941e80a8f11a9a2d6185bed6c22b30345f0bd839b9efacbca2b9d6620a68f7f13bf906abb978848bd813f82227d95371e9d860da0a5bca787c",
                            "Explain": "结合患者的心电图，考虑为心房颤动，控制心室率可以保证心脏基本功能，尽可能降低心房颤动引起的心脏功能紊乱，β受体阻断剂是最有效、最常用和常单独应用的药物。",
                            "TestPoint": "",
                            "Answer": "A",
                            "Difficulty": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "美托洛尔"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "阿托品"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "沙丁胺醇"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "新斯的明"
                                }
                            ],
                            "StyleType": "ATEST",
                            "AllTestID": 43015446,
                            "ATestID": 43015446,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "IsFav": 0,
                            "UserNoteContent": "",
                            "DealInfo": ""
                        }
                    ]
                },
                {
                    "StyleID": 3,
                    "Style": "B1型题",
                    "Explain": "B1型题：以下提供若干组考题，每组考题共用在考题前列出的A、B、C、D、E五个备选答案。请从中选择一个与问题关系最密切的答案。某个备选答案可能被选择一次、多次或不被选择。",
                    "Score": 1,
                    "Type": "BTEST",
                    "SubType": "单项",
                    "TestCount": 9,
                    "TestItems": [
                        {
                            "Title": "dabcb1acefc163a2403e8eee4303a8111252a7aaf5db8f3dfd5c7d64c74d55cd76c5abc143087a0bb9790b2134c47f068a8a525740b0b258",
                            "Explain": "①心力衰竭合并快速心房颤动的患者应该及时控制其心室率，保证心室充盈，首选洋地黄类药物，因为洋地黄类药物有正性肌力（加强心收缩力）、负性频率（减慢心率）、负性传导（减慢房室结传导）的作用，从而缓解心功能不全的症状，房颤得到控制，故9题选B。②毛花苷C（西地兰）属于洋地黄类药物。③普罗帕酮属于钙通道阻滞剂，能降低浦肯野纤维及心室肌的自律性，减慢传导速度，另外有弱的P受体阻断作用，有轻度负性肌力作用，因此适用于室上性及室性早搏、心动过速及预防综合征合并心动过速或心房纤颤者，可作为频发室性期前收缩的首选治疗药。故10题选C。",
                            "TestPoint": "",
                            "Answer": "B",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "三磷酸腺苷"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "西地兰"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "普罗帕酮"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "阿托品"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "异丙肾上腺素"
                                }
                            ],
                            "AllTestID": 35000568,
                            "BTestID": 35000126,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "BTestItems": [
                                {
                                    "BTestItemID": 35000126,
                                    "Title": "dabcb1acefc163a2403e8eee4303a8111252a7aaf5db8f3dfd5c7d64c74d55cd76c5abc143087a0bb9790b2134c47f068a8a525740b0b258",
                                    "Explain": "①心力衰竭合并快速心房颤动的患者应该及时控制其心室率，保证心室充盈，首选洋地黄类药物，因为洋地黄类药物有正性肌力（加强心收缩力）、负性频率（减慢心率）、负性传导（减慢房室结传导）的作用，从而缓解心功能不全的症状，房颤得到控制，故9题选B。②毛花苷C（西地兰）属于洋地黄类药物。③普罗帕酮属于钙通道阻滞剂，能降低浦肯野纤维及心室肌的自律性，减慢传导速度，另外有弱的P受体阻断作用，有轻度负性肌力作用，因此适用于室上性及室性早搏、心动过速及预防综合征合并心动过速或心房纤颤者，可作为频发室性期前收缩的首选治疗药。故10题选C。",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 35000127,
                                    "Title": "f532991ea03f1424dad3ed9df7532ed632f90a54ffa2465abe99cf9d56010ef5fd971e0e545c073e",
                                    "Explain": "①心力衰竭合并快速心房颤动的患者应该及时控制其心室率，保证心室充盈，首选洋地黄类药物，因为洋地黄类药物有正性肌力（加强心收缩力）、负性频率（减慢心率）、负性传导（减慢房室结传导）的作用，从而缓解心功能不全的症状，房颤得到控制，故9题选B。②毛花苷C（西地兰）属于洋地黄类药物。③普罗帕酮属于钙通道阻滞剂，能降低浦肯野纤维及心室肌的自律性，减慢传导速度，另外有弱的P受体阻断作用，有轻度负性肌力作用，因此适用于室上性及室性早搏、心动过速及预防综合征合并心动过速或心房纤颤者，可作为频发室性期前收缩的首选治疗药。故10题选C。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "62d3809b7c6c5ad229dd7da2cd9423c71b757fd6f391ce6b24693fe0f90b96ec0d0584fb0abd4435",
                            "Explain": "胺碘酮对甲状腺和甲状腺激素的影响机制，主要包括以下几个方面［3］：（1）代谢过程中释放出大量碘，抑制甲状腺吸收碘和合成甲状腺激素，即所谓Wolff-Chaikoff效应。此效应于服用胺碘酮头2周内最明显。（2）在外周，胺碘酮对5’-脱碘酶具特异性抑制作用，导致外周细胞中T4转化为T3减少。这种抑制作用持续整个胺碘酮应用期间，直至停药后数月之久。",
                            "TestPoint": "抗心律失常药",
                            "Answer": "D",
                            "Difficulty": "难",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "奎尼丁"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "普鲁卡因胺"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "利多卡因"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "胺碘酮"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "维拉帕米"
                                }
                            ],
                            "AllTestID": 43002698,
                            "BTestID": 43000687,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43000687,
                                    "Title": "62d3809b7c6c5ad229dd7da2cd9423c71b757fd6f391ce6b24693fe0f90b96ec0d0584fb0abd4435",
                                    "Explain": "胺碘酮对甲状腺和甲状腺激素的影响机制，主要包括以下几个方面［3］：（1）代谢过程中释放出大量碘，抑制甲状腺吸收碘和合成甲状腺激素，即所谓Wolff-Chaikoff效应。此效应于服用胺碘酮头2周内最明显。（2）在外周，胺碘酮对5’-脱碘酶具特异性抑制作用，导致外周细胞中T4转化为T3减少。这种抑制作用持续整个胺碘酮应用期间，直至停药后数月之久。",
                                    "TestPoint": "抗心律失常药",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000688,
                                    "Title": "474e832d631e41ebfeec2fbc1bd87999d34601699b8521708d5183c3bf0e05fff1786f8b92cda53a",
                                    "Explain": "长期应用胺碘酮后，个别患者可出现弥漫性肺纤维化，发病机制不明确，发病多从肺泡炎开始，以纤维化告终。",
                                    "TestPoint": "抗心律失常药",
                                    "Answer": "D",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43000689,
                                    "Title": "d43a37c9100f37fa93d1961d58f87a1d2e7fae6e85cbe6c5e29030ecf870361ed706dc08d71e6c14a67f6ac3fab2ad45a72fd9a3e98f7865f4d32fbb45429cc0",
                                    "Explain": "长期用药可引起全身红斑狼疮样综合征的药物是含有芳香族胺基团或联胺基团的药物，机制尚未明确。",
                                    "TestPoint": "系统性红斑狼疮",
                                    "Answer": "B",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        },
                        {
                            "Title": "474e832d631e41ebf1122147ba34aefc422ce2f03ce392cbddb1328914b9f95ce2f81ac691db4a20",
                            "Explain": "",
                            "TestPoint": "",
                            "Answer": "E",
                            "Difficulty": "",
                            "StyleType": "BTEST",
                            "SubStyleType": "ATEST",
                            "FrontTitle": "",
                            "SelectedItems": [
                                {
                                    "ItemName": "A",
                                    "Content": "卡托普利"
                                },
                                {
                                    "ItemName": "B",
                                    "Content": "硝苯地平"
                                },
                                {
                                    "ItemName": "C",
                                    "Content": "氢氯噻嗪"
                                },
                                {
                                    "ItemName": "D",
                                    "Content": "甲氨蝶岭"
                                },
                                {
                                    "ItemName": "E",
                                    "Content": "美托洛尔"
                                }
                            ],
                            "AllTestID": 43015445,
                            "BTestID": 43002847,
                            "SrcID": 9,
                            "SbjID": 39,
                            "CptID": 331,
                            "BTestItems": [
                                {
                                    "BTestItemID": 43002847,
                                    "Title": "474e832d631e41ebf1122147ba34aefc422ce2f03ce392cbddb1328914b9f95ce2f81ac691db4a20",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "E",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43002848,
                                    "Title": "c3196268d3bac5cbfadfd6a680acd31f256ad9cbe4955a95e7b6444ce361ec472c4a09356dd887e6",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "B",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43002849,
                                    "Title": "49d74e136dfca6231468d62fc2ebb1304959522204fb805a3d261074cddb849aa26f11dbfc0749aa",
                                    "Explain": "",
                                    "TestPoint": "",
                                    "Answer": "A",
                                    "DealInfo": ""
                                },
                                {
                                    "BTestItemID": 43002850,
                                    "Title": "474e832d631e41ebdf9b83cd49a9a8e19b0529755132ce6c0515cdd98e2a8247",
                                    "Explain": "β受体阻断剂可以通过减慢心率、降低血压、减弱心肌收缩力而使心肌耗氧量下降，即在完成相同功量的运动时心率×血压二者乘积较前减少。硝苯地平的主要缺点是开始治疗阶段有反射性交感活性增强，尤其是使用短效制剂，引起心率增快、面部潮红、头痛、下肢水肿等。非二氢吡啶类抑制心肌收缩及自律性和传导性，不宜在心力衰竭、窦房结功能低下或心脏传导阻滞患者中应用。干咳发生率约10%～20%，可能与体内缓激肽增多有关，停用后可消失。高钾血症、妊娠妇女和双侧肾动脉狭窄患者禁用。血肌酐超过265μmol/L的患者使用时需谨慎。氢氨噻嗪属噻嗪类利尿剂，在临床上应用最普遍，但长期应用可引起血钾降低及血糖、血尿酸、血胆固醇增高，糖尿病及高脂血症患者宜慎用，痛风患者禁用。",
                                    "TestPoint": "",
                                    "Answer": "C",
                                    "DealInfo": ""
                                }
                            ],
                            "IsFav": 0,
                            "UserNoteContent": ""
                        }
                    ]
                }
            ]
        },
        "isVip": 0,
        "testInfo": [
            {
                "AllTestID": 43000517,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43000517,
                        "ChildTableID": -1,
                        "UserCount": 2414,
                        "RightCount": 1983,
                        "FavCount": 35,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 20
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43000517,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 20
            },
            {
                "AllTestID": 43002689,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002689,
                        "ChildTableID": -1,
                        "UserCount": 2623,
                        "RightCount": 1137,
                        "FavCount": 79,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 16
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002689,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 16
            },
            {
                "AllTestID": 43002691,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002691,
                        "ChildTableID": -1,
                        "UserCount": 2511,
                        "RightCount": 1565,
                        "FavCount": 48,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002691,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002692,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002692,
                        "ChildTableID": -1,
                        "UserCount": 2438,
                        "RightCount": 1360,
                        "FavCount": 48,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002692,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002693,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002693,
                        "ChildTableID": -1,
                        "UserCount": 2477,
                        "RightCount": 1565,
                        "FavCount": 54,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 28
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002693,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 28
            },
            {
                "AllTestID": 43002694,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002694,
                        "ChildTableID": -1,
                        "UserCount": 2320,
                        "RightCount": 1262,
                        "FavCount": 56,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 16
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002694,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 16
            },
            {
                "AllTestID": 43002695,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002695,
                        "ChildTableID": -1,
                        "UserCount": 2303,
                        "RightCount": 1062,
                        "FavCount": 50,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 18
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002695,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 18
            },
            {
                "AllTestID": 43002696,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002696,
                        "ChildTableID": -1,
                        "UserCount": 2335,
                        "RightCount": 1223,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 13
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002696,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 13
            },
            {
                "AllTestID": 43015439,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015439,
                        "ChildTableID": -1,
                        "UserCount": 2172,
                        "RightCount": 1289,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015439,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43015441,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015441,
                        "ChildTableID": -1,
                        "UserCount": 2176,
                        "RightCount": 1624,
                        "FavCount": 40,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 11
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015441,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 11
            },
            {
                "AllTestID": 43015442,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015442,
                        "ChildTableID": -1,
                        "UserCount": 2215,
                        "RightCount": 1042,
                        "FavCount": 47,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 10
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015442,
                    "ChildTableID": -1
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 10
            },
            {
                "AllTestID": 43015443,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015443,
                        "ChildTableID": -1,
                        "UserCount": 2143,
                        "RightCount": 1277,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 16
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015443,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 16
            },
            {
                "AllTestID": 43015444,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015444,
                        "ChildTableID": -1,
                        "UserCount": 2043,
                        "RightCount": 1797,
                        "FavCount": 29,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015444,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 41000530,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000530,
                        "ChildTableID": -1,
                        "UserCount": 2171,
                        "RightCount": 1734,
                        "FavCount": 25,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 8
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000530,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 8
            },
            {
                "AllTestID": 41000531,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 41000531,
                        "ChildTableID": -1,
                        "UserCount": 2106,
                        "RightCount": 1913,
                        "FavCount": 19,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 41000531,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43002697,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002697,
                        "ChildTableID": -1,
                        "UserCount": 2155,
                        "RightCount": 1630,
                        "FavCount": 37,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002697,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43015446,
                "ChildTableID": -1,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015446,
                        "ChildTableID": -1,
                        "UserCount": 2084,
                        "RightCount": 1318,
                        "FavCount": 42,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015446,
                    "ChildTableID": -1
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            },
            {
                "AllTestID": 35000568,
                "ChildTableID": 35000126,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 35000568,
                        "ChildTableID": 35000126,
                        "UserCount": 2232,
                        "RightCount": 1389,
                        "FavCount": 46,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 12
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 35000568,
                    "ChildTableID": 35000126
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 12
            },
            {
                "AllTestID": 35000568,
                "ChildTableID": 35000127,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 35000568,
                        "ChildTableID": 35000127,
                        "UserCount": 2178,
                        "RightCount": 1767,
                        "FavCount": 44,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 35000568,
                    "ChildTableID": 35000127
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43002698,
                "ChildTableID": 43000687,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002698,
                        "ChildTableID": 43000687,
                        "UserCount": 2220,
                        "RightCount": 1392,
                        "FavCount": 48,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 21
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002698,
                    "ChildTableID": 43000687
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 21
            },
            {
                "AllTestID": 43002698,
                "ChildTableID": 43000688,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002698,
                        "ChildTableID": 43000688,
                        "UserCount": 2256,
                        "RightCount": 1055,
                        "FavCount": 52,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 27
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002698,
                    "ChildTableID": 43000688
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 27
            },
            {
                "AllTestID": 43002698,
                "ChildTableID": 43000689,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43002698,
                        "ChildTableID": 43000689,
                        "UserCount": 2259,
                        "RightCount": 885,
                        "FavCount": 61,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 20
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43002698,
                    "ChildTableID": 43000689
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 20
            },
            {
                "AllTestID": 43015445,
                "ChildTableID": 43002847,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015445,
                        "ChildTableID": 43002847,
                        "UserCount": 2062,
                        "RightCount": 1691,
                        "FavCount": 22,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015445,
                    "ChildTableID": 43002847
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43015445,
                "ChildTableID": 43002848,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015445,
                        "ChildTableID": 43002848,
                        "UserCount": 2077,
                        "RightCount": 1575,
                        "FavCount": 30,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 15
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015445,
                    "ChildTableID": 43002848
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 15
            },
            {
                "AllTestID": 43015445,
                "ChildTableID": 43002849,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015445,
                        "ChildTableID": 43002849,
                        "UserCount": 2031,
                        "RightCount": 1665,
                        "FavCount": 17,
                        "DiscussionCount": 1,
                        "ExplainCount": 0,
                        "ConcernCount": 9
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015445,
                    "ChildTableID": 43002849
                },
                "DiscussionCount": 1,
                "ExplainCount": 0,
                "ConcernCount": 9
            },
            {
                "AllTestID": 43015445,
                "ChildTableID": 43002850,
                "Correction": [],
                "Statistics": {
                    "Correction": [],
                    "Test": {
                        "AppID": 1328,
                        "AllTestID": 43015445,
                        "ChildTableID": 43002850,
                        "UserCount": 2015,
                        "RightCount": 1811,
                        "FavCount": 21,
                        "DiscussionCount": 0,
                        "ExplainCount": 0,
                        "ConcernCount": 7
                    }
                },
                "Analysis": [],
                "KnowledgePoint": {
                    "Summary": null,
                    "KnowledgeText": null,
                    "AllTestID": 43015445,
                    "ChildTableID": 43002850
                },
                "DiscussionCount": 0,
                "ExplainCount": 0,
                "ConcernCount": 7
            }
        ],
        "info": [],
        "encoded": 1,
        "examHistoryID": 0,
        "yimoinfo": [],
        "UserTime": 0
    },
    "status": 200
}